Circulating tryptase as a marker for subclinical atherosclerosis in obese subjects

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Moreno, Maria ^a   Puig, Josep ^a   Serrano, Marta ^a   Moreno Navarrete, José María ^a   Ortega, Francisco ^a   Ricart, Wifredo ^a   Fernandez Real, Jose Manuel ^a  

^a GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; INSULIN; TRIACYLGLYCEROL; TRYPTASE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; ECHOGRAPHY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FAT MASS; FEMALE; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYMERASE CHAIN REACTION; SCORING SYSTEM; AGED; ANTHROPOMETRY; BLOOD; BODY COMPOSITION; CHEMISTRY; COMPLICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; RISK FACTOR;

ADULT; AGED; ANTHROPOMETRY; ATHEROSCLEROSIS; BODY COMPOSITION; CAROTID INTIMA-MEDIA THICKNESS; CHOLESTEROL, HDL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; OBESITY; POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; RISK FACTORS; ROC CURVE; TRIGLYCERIDES; TRYPTASES;

EID: 84901353736     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097014     Document Type: Article

References (34)

1. Hakala JK, Oksjoki R, Laine P, Du H, Grabowski GA, et al. (2003) Lysosomal enzymes are released from cultured human macrophages, hydrolyze LDL in vitro, and are present extracellularly in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 23:1430-6 (Pubitemid 37006376)
2. Fuster V, Moreno PR, Fayad ZA, Corti R, Badimon JJ (2005) Atherothrombosis and high-risk plaque: part I: evolving concepts. J Am Coll Cardiol 46:937-54. (Pubitemid 41316498)
3. Hansson GK, Libby P (2006) The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6:508-19. (Pubitemid 43980523)
4. Metcalfe DD(2008) Mast cells and mastocytosis. Blood 112:946-56.
5. De Filippis D, D'Amico A, Iuvone T (2008) Cannabinomimetic control of mast cell mediator release: new perspective in chronic inflammation. J Neuroendocrinol 20:20-5 (Pubitemid 351552672)
6. Kelley JL, Chi DS, bou-Auda W, Smith JK, Krishnaswamy G (2000) The molecular role of mast cells in atherosclerotic cardiovascular disease. Mol Med Today 6:304-8 (Pubitemid 30619337)
7. Kaartinen M, Penttilä A, Kovanen PT (1994) Mast cells of two types differing in neutral protease composition in the human aortic intima. Demonstration of tryptase- and tryptase/chymase-containing mast cells in normal intimas, fatty streaks, and the shoulder region of atheromas. Arterioscler Thromb 14:966-72
8. Schwartz LB (1990) Tryptase, a mediator of human mast cells. J Allergy Clin Immunol 86:594-8
9. Thomas VA, Wheeless CJ, Stack MS, Johnson DA (1998) Human mast cell tryptase fibrinogenolysis: kinetics, anticoagulation mechanism, and cell adhesion disruption. Biochemistry 37:2291-8. (Pubitemid 28119302)
10. Kovanen PT, Kaartinen M, Paavonen T (1995) Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 92:1084-8
11. Fukuoka Y, Schwartz LB (2007) Active monomers of human beta-tryptase have expanded substrate specificities. Int Immunopharmacol 7:1900-8 (Pubitemid 350138517)
12. Xiang M, Sun J, Lin Y, Zhang J, Chen H, et al. (2011) Usefulness of serum tryptase level as an independent biomarker for coronary plaque instability in a Chinese population. Atherosclerosis 215:494-9
13. Deliargyris EN, Upadhya B, Sane DC, Dehmer GJ, Pye J, et al. (2005) Mast cell tryptase: a new biomarker in patients with stable coronary artery disease. Atherosclerosis 178:381-6. (Pubitemid 40193455)
14. Zhi X, Xu C, Zhang H, Tian D, Li X, et al. (2013) Tryptase promotes atherosclerotic plaque haemorrhage in ApoE-/- mice. PLoS One 8:e60960
15. Fukuoka Y, Schwartz LB (2007) Active monomers of human beta-tryptase have expanded substrate specificities. Int Immunopharmacol 7:1900-8 (Pubitemid 350138517)
16. Schwartz LB, Bradford TR, Littman BH, Wintroub BU (1985) The fibrinogenolytic activity of purified tryptase from human lung mast cells. J Immunol 135:2762-7. (Pubitemid 16217148)
17. Ramalho LS, Oliveira LF, Cavellani CL, Ferraz ML, de Oliveira FA, et al. (2013) Role of mast cell chymase and tryptase in the progression of atherosclerosis: study in 44 autopsied cases. Ann Diagn Pathol 17:28-31
18. Willems S, Vink A, Bot I, Quax PH, de Borst GJ, et al. (2013) Mast cells in human carotid atherosclerotic plaques are associated with intraplaque microvessel density and the occurrence of future cardiovascular events. Eur Heart J 34:3699-706
19. Liu J, Divoux A, Sun J, Zhang J, Clément K, et al. (2009) Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med 15:940-5
20. Fenger RV, Linneberg A, Vidal C, Vizcaino L, Husemoen LL, et al. (2012) Determinants of serum tryptase in a general population: the relationship of serum tryptase to obesity and asthma. Int Arch Allergy Immunol 157:151-8
21. Divoux A, Moutel S, Poitou C, Lacasa D, Veyrie N, et al. (2012) Mast cells in human adipose tissue: link with morbid obesity, inflammatory status, and diabetes. J Clin Endocrinol Metab 97:E1677-85
22. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, et al. (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340:14-22. (Pubitemid 29024679)
23. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, et al. (2012) Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011).
24. An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis 34:290-6
25. Lehtonen-Smeds EM, Mayranpaa M, Lindsberg PJ, Soinne L, Saimanen E, et al. (2005) Carotid plaque mast cells associate with atherogenic serum lipids, high grade carotid stenosis and symptomatic carotid artery disease. Results from the helsinki carotid endarterectomy study. Cerebrovasc Dis 19:291-301 (Pubitemid 40663305)
26. Wang Z, Zhang H, Shen XH, Jin KL, Ye GF, et al. (2011)Immunoglobulin E and mast cell proteases are potential risk factors of human pre-diabetes and diabetes mellitus. PLoS One 6:e28962.
27. Wang Z, Zhang H, Shen XH, Jin KL, Ye GF, et al. (2013) Immunoglobulin E and mast cell proteases are potential risk factors of impaired fasting glucose and impaired glucose tolerance in humans. Ann Med 45:220-9
28. Bot I, Biessen EA (2011) Mast cells in atherosclerosis. Thromb Haemost 106:820-826.
29. Kovanen PT (1990) Atheroma formation: defective control in the intimal round-trip of cholesterol. Eur Heart J 11:238-46
30. Lee M, Sommerhoff CP, von Eckardstein A, Zettl F, Fritz H, et al. (2002) Mast cell tryptase degrades HDL and blocks its function as an acceptor of cellular cholesterol. Arterioscler Thromb Vasc Biol 22:2086-91. (Pubitemid 36025219)
31. Kervinen H, Kaartinen M, Mäkynen H, Palosuo T, Mänttäri M, et al. (2005) Serum tryptase levels in acute coronary syndromes. Int J Cardiol 104:138-43. (Pubitemid 41316981)
32. Lindstedt KA, Kokkonen JO, Kovanen PT (1998) Regulation of the activity of secreted human lung mast cell tryptase by mast cell proteoglycans. Biochim Biophys Acta 1425:617-27 (Pubitemid 28546696)
33. Johnson JL, Jackson CL, Angelini GD, George SJ (1998) Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 18:1707-15 (Pubitemid 28521059)
34. Bots ML, Baldassarre D, Simon A, de Groot E, O'Leary DH, et al. (2007) Carotid intima media thickness and coronary atherosclerosis: weak or strong relations? Eur Heart J 28: 398-406 (Pubitemid 47343565)